• Architects in Delhi
    Delhi is the bustling capital city of India and is a hub of architectural wonders. From historical monuments to ultra-modern skyscrapers, the city boasts a wide range of architectural styles. Architects in Delhi is well-known for their unique style that basically combines tropical home architecture with global trends, and for making use of local materials. They also work across diverse sectors such as residential, commercial, as well as institutional, creating spaces that are both functional and artistically pleasing.
    https://www.designforuminternational.com/portfolio/vanijya-bhawan-delhi/
    Architects in Delhi Delhi is the bustling capital city of India and is a hub of architectural wonders. From historical monuments to ultra-modern skyscrapers, the city boasts a wide range of architectural styles. Architects in Delhi is well-known for their unique style that basically combines tropical home architecture with global trends, and for making use of local materials. They also work across diverse sectors such as residential, commercial, as well as institutional, creating spaces that are both functional and artistically pleasing. https://www.designforuminternational.com/portfolio/vanijya-bhawan-delhi/
    0 Comentários 0 Compartilhamentos 317 Visualizações
  • High-Quality Low Tension Aluminium Cable – Deshraj Cables

    Deshraj Cables offers top-grade low tension aluminium cables designed for efficient power distribution and long-lasting performance. Ideal for industrial, commercial, and residential use, our LT aluminium cables are ISI-certified, corrosion-resistant, and built to meet safety standards. Trusted by professionals across India.

    For more info: https://www.deshrajcable.com/low-tension-aluminium-cable.html

    Loc: C- 24, Meerut Road Industrial Area, Ghaziabad (U.p.)-201001.

    Contact: [email protected]
    High-Quality Low Tension Aluminium Cable – Deshraj Cables Deshraj Cables offers top-grade low tension aluminium cables designed for efficient power distribution and long-lasting performance. Ideal for industrial, commercial, and residential use, our LT aluminium cables are ISI-certified, corrosion-resistant, and built to meet safety standards. Trusted by professionals across India. For more info: https://www.deshrajcable.com/low-tension-aluminium-cable.html Loc: C- 24, Meerut Road Industrial Area, Ghaziabad (U.p.)-201001. Contact: [email protected]
    Low Tension Aluminium Cable Manufacturers - deshrajcable.com
    Low Tension Aluminium Cable Manufacturers - DESHRAJ CABLE is a trusted Low Tension Aluminium Cable, providing durable and efficient solutions for aerial power distribution with enhanced safety and performance.
    0 Comentários 0 Compartilhamentos 304 Visualizações
  • PVC Electrical Pipe Manufacturers

    Ashish Pipes is one of the leading PVC Electrical Pipe Manufacturers in India, offering high-quality, durable, and cost-effective electrical conduit solutions. Our PVC pipes are designed to provide excellent protection for wiring in residential, commercial, and industrial setups. As trusted PVC Electrical Pipe Manufacturers, we ensure superior strength, fire resistance, and easy installation. Choose Ashish Pipes for reliable and efficient electrical piping systems that meet all industry standards.

    Visit: https://www.ashishpipes.in/pvc-conduit-pipes/

    Add: B-57 & 58, Sector-81,Phase II, Noida

    Ph: 0120-42-222-07

    Email: [email protected]
    PVC Electrical Pipe Manufacturers Ashish Pipes is one of the leading PVC Electrical Pipe Manufacturers in India, offering high-quality, durable, and cost-effective electrical conduit solutions. Our PVC pipes are designed to provide excellent protection for wiring in residential, commercial, and industrial setups. As trusted PVC Electrical Pipe Manufacturers, we ensure superior strength, fire resistance, and easy installation. Choose Ashish Pipes for reliable and efficient electrical piping systems that meet all industry standards. Visit: https://www.ashishpipes.in/pvc-conduit-pipes/ Add: B-57 & 58, Sector-81,Phase II, Noida Ph: 0120-42-222-07 Email: [email protected]
    WWW.ASHISHPIPES.IN
    Best PVC Conduit Pipe Manufacturers | Noida | India
    Best PVC Conduit Pipe Manufacturers -Ashish Pipes are well-known for providing the Best PVC Conduit Pipe in Noida, Uttar Pradesh, India. Get here the High Quality PVC Conduit Pipe at best Price.
    0 Comentários 0 Compartilhamentos 300 Visualizações
  • Leading Commercial Kitchen Manufacturers- Mahto Kitchen


    Mahto Kitchen is a trusted name among commercial kitchen manufacturers in India, specializing in high-performance kitchen setups for hotels, restaurants, catering units, and cloud kitchens. With a focus on durability, hygiene, and efficiency, Mahto Kitchen delivers custom-designed solutions using premium-grade stainless steel and modern technology. From planning to installation, we provide end-to-end commercial kitchen equipment and layout services to meet all your culinary business needs.

    For more info: https://www.mahtokitchen.com/commercial-kitchen-equipment.html

    Work: Khasra No. 76, R.K. Kaushik Marg, Ranholla Village, Near Shiv Mandir, New Delhi - 110041, India

    Contact: [email protected]

    Leading Commercial Kitchen Manufacturers- Mahto Kitchen Mahto Kitchen is a trusted name among commercial kitchen manufacturers in India, specializing in high-performance kitchen setups for hotels, restaurants, catering units, and cloud kitchens. With a focus on durability, hygiene, and efficiency, Mahto Kitchen delivers custom-designed solutions using premium-grade stainless steel and modern technology. From planning to installation, we provide end-to-end commercial kitchen equipment and layout services to meet all your culinary business needs. For more info: https://www.mahtokitchen.com/commercial-kitchen-equipment.html Work: Khasra No. 76, R.K. Kaushik Marg, Ranholla Village, Near Shiv Mandir, New Delhi - 110041, India Contact: [email protected]
    0 Comentários 0 Compartilhamentos 483 Visualizações
  • Top Distribution Transformer Manufacturers in Jammu and Kashmir – Virdi Transformers

    Virdi Transformers is a trusted name among distribution transformer manufacturers in Jammu and Kashmir. We offer high-performance, energy-efficient transformers built to meet industry standards. Our products ensure reliable power distribution across commercial, industrial, and rural sectors. With years of expertise, we deliver customized solutions, on-time delivery, and strong after-sales support across J&K.


    For more info: https://www.virditransformer.com/distribution-transformer-jammu-kashmir.html

    Work: C-21, Sector-63, Noida-201301, Uttar Pradesh-201301

    Contact: [email protected], [email protected]
    Top Distribution Transformer Manufacturers in Jammu and Kashmir – Virdi Transformers Virdi Transformers is a trusted name among distribution transformer manufacturers in Jammu and Kashmir. We offer high-performance, energy-efficient transformers built to meet industry standards. Our products ensure reliable power distribution across commercial, industrial, and rural sectors. With years of expertise, we deliver customized solutions, on-time delivery, and strong after-sales support across J&K. For more info: https://www.virditransformer.com/distribution-transformer-jammu-kashmir.html Work: C-21, Sector-63, Noida-201301, Uttar Pradesh-201301 Contact: [email protected], [email protected]
    Distribution Transformer Manufacturers in Jammu and Kashmir - Virdi Electri specializes in Distribution Transformer Manufacturers in Bihar to ensure optimal performance of electrical equipment.
    0 Comentários 0 Compartilhamentos 305 Visualizações
  • AC Maintenance Services in Dubai: Keeping Your Cooling Systems Efficient Year-Round

    .
    .
    In Dubai’s extreme climate, where summer temperatures often soar above 45°C (113°F), air conditioning isn’t just a luxury—it's a necessity. Whether it’s a residential apartment, office building, villa, or commercial space, regular AC maintenance services in Dubai are essential to ensure that cooling systems operate efficiently, economically, and safely.

    https://armoredandstrong.ae/book-ac-servicing-dubai/ac-servicing-in-dubai/
    AC Maintenance Services in Dubai: Keeping Your Cooling Systems Efficient Year-Round . . In Dubai’s extreme climate, where summer temperatures often soar above 45°C (113°F), air conditioning isn’t just a luxury—it's a necessity. Whether it’s a residential apartment, office building, villa, or commercial space, regular AC maintenance services in Dubai are essential to ensure that cooling systems operate efficiently, economically, and safely. https://armoredandstrong.ae/book-ac-servicing-dubai/ac-servicing-in-dubai/
    AC Servicing in Dubai | Installation | Repair | Home Maintenance Company
    Book your AC Servicing in Dubai from Armored and Strong. We are the best AC maintenance service providers in Dubai.
    0 Comentários 0 Compartilhamentos 260 Visualizações
  • Discover premium Aluminium Door Handles at eurohardware.co.uk – the trusted source for stylish, durable, and corrosion-resistant hardware solutions. Perfect for modern and commercial spaces.

    https://eurohardware.co.uk/aluminium-door-handles-the-perfect-blend-of-strength-style-and-value/

    #DoorHandles #AluminiumDoorHandles #Eurohardware
    Discover premium Aluminium Door Handles at eurohardware.co.uk – the trusted source for stylish, durable, and corrosion-resistant hardware solutions. Perfect for modern and commercial spaces. https://eurohardware.co.uk/aluminium-door-handles-the-perfect-blend-of-strength-style-and-value/ #DoorHandles #AluminiumDoorHandles #Eurohardware
    0 Comentários 0 Compartilhamentos 350 Visualizações
  • Explore Famous Museum in Dubai With BookMyBooking

    Explore every famous museum in Dubai—from the futuristic Museum of the Future to historical gems like Etihad and Dubai Museum. Discover the city’s rich past and vibrant future with BookMyBooking.

    Read More:- https://www.bookmybooking.com/blogs/united-arab-emirates-uae/museums-in-dubai

    Contact Now :

    Company Name - INSTA TOURISM LLC

    Address - 201, M Square Commercial Building, Near Double Tree Hotel, Bur Dubai, Dubai, UAE 120375

    WhatsApp Support: +971 - 55 590 3386

    India (Phone Support): +91 - 011 4242 8686 (Available 24/7)

    UAE (Phone Support): +971 - 45464650 (Available 10 to 7 Monday to Saturday)

    Email Support: [email protected]


    Explore Famous Museum in Dubai With BookMyBooking Explore every famous museum in Dubai—from the futuristic Museum of the Future to historical gems like Etihad and Dubai Museum. Discover the city’s rich past and vibrant future with BookMyBooking. Read More:- https://www.bookmybooking.com/blogs/united-arab-emirates-uae/museums-in-dubai Contact Now : Company Name - INSTA TOURISM LLC Address - 201, M Square Commercial Building, Near Double Tree Hotel, Bur Dubai, Dubai, UAE 120375 ✅WhatsApp Support: +971 - 55 590 3386 📞India (Phone Support): +91 - 011 4242 8686 (Available 24/7) 📞UAE (Phone Support): +971 - 45464650 (Available 10 to 7 Monday to Saturday) Email Support: [email protected]
    WWW.BOOKMYBOOKING.COM
    Top Museums in Dubai – Discover Dubai’s Rich Cultural Heritage
    Explore the best museums in Dubai, from the Dubai Museum to the Etihad Museum. Discover the rich history, culture, and heritage of Dubai with our comprehensive guide.
    0 Comentários 0 Compartilhamentos 366 Visualizações
  • Transformers Manufacturers

    Macroplast Transformers is one of the leading Transformers Manufacturers in India, offering a wide range of high-quality and energy-efficient transformers for various industrial and commercial applications. With a strong commitment to innovation and performance, Macroplast ensures reliable and durable solutions tailored to client needs. As trusted Transformers Manufacturers, we adhere to international standards and deliver exceptional service and support. Visit macroplasttransformers.com to explore our product range.

    Visit: https://www.macroplasttransformers.com/blog/top-10-power-transformer-manufacturers-company-in-india/

    Add: D-18/2, Surajpur Industrial Area,Site-B, Greater Noida, Gautam Buddh Nagar, U.P, India Pin Code - 201306

    Ph: +91-9958904598

    Email: [email protected]

    Transformers Manufacturers Macroplast Transformers is one of the leading Transformers Manufacturers in India, offering a wide range of high-quality and energy-efficient transformers for various industrial and commercial applications. With a strong commitment to innovation and performance, Macroplast ensures reliable and durable solutions tailored to client needs. As trusted Transformers Manufacturers, we adhere to international standards and deliver exceptional service and support. Visit macroplasttransformers.com to explore our product range. Visit: https://www.macroplasttransformers.com/blog/top-10-power-transformer-manufacturers-company-in-india/ Add: D-18/2, Surajpur Industrial Area,Site-B, Greater Noida, Gautam Buddh Nagar, U.P, India Pin Code - 201306 Ph: +91-9958904598 Email: [email protected]
    WWW.MACROPLASTTRANSFORMERS.COM
    Top 10 leading Power Transformer Manufacturers Company in India
    If you want to know the Top 10 leading Power Transformer Manufacturers Company in India. Read our blog for more details!!
    0 Comentários 0 Compartilhamentos 290 Visualizações
  • Global Stirling Engine Market Size To Grow At A CAGR Of 9.6% In The Forecast Period Of 2023-2030

    Antibody–Drug Conjugate (ADC) Technology Market is projected to expand from USD 6.5 billion in 2023 to USD 19.8 billion by 2029, growing at a CAGR of approximately 20.2% during the forecast period. This surge is fueled by the rising demand for targeted cancer therapies, expansion in oncology research, and breakthrough drug approvals, which are transforming the treatment landscape for solid tumors and hematologic malignancies.

    Request Free Sample Report:https://www.maximizemarketresearch.com/request-sample/216553/

    Market Estimation, Growth Drivers & Opportunities
    ADCs represent a sophisticated drug delivery platform that merges the precision of monoclonal antibodies with the potency of cytotoxic drugs. This targeted approach is enabling higher efficacy and lower toxicity in treating cancers, particularly breast, bladder, and hematologic malignancies.

    Key Growth Drivers:

    Increasing cancer burden globally, with a growing demand for effective and less harmful therapies.

    High success rate of late-stage ADCs, particularly in HER2-positive and triple-negative breast cancer, driving physician and patient adoption.

    Collaborative R&D and licensing deals between biotech startups and pharmaceutical giants, speeding up clinical development and commercialization.

    Opportunities:

    Expansion into non-oncology indications, such as autoimmune diseases.

    Development of next-generation ADC linkers and site-specific conjugation technologies, enhancing stability and efficacy.

    Rising demand in Asia-Pacific for innovative oncology treatments due to increasing access to biologics.U.S. Market Trends and 2024 Investments

    The U.S. ADC market leads globally, accounting for over 40% of global revenue in 2024. Several trends and investments highlight the country's strategic focus:

    Pfizer’s acquisition of Seagen in 2023, worth $43 billion, marked a pivotal moment for the ADC space. This move bolstered Pfizer’s oncology pipeline with four marketed ADCs and several candidates in Phase II/III trials.

    FDA approvals of ADCs surged in 2023–2024, with significant attention to Enhertu (AstraZeneca/Daiichi Sankyo) and Elahere (ImmunoGen).

    NIH and BARDA funding initiatives are also supporting translational research on ADC payload optimization and companion diagnostics.

    This environment positions the U.S. as the primary innovation and commercialization hub for ADCs.

    Market Segmentation – Leading Segments by Share
    According to the segmentation analysis:

    By Type: The monoclonal antibodies (mAbs) segment held the largest share due to the widespread use of FDA-approved antibodies like trastuzumab and rituximab as carriers for ADCs.

    By Application: Breast cancer accounted for the largest share, driven by the success of HER2-targeted ADCs such as Enhertu and Kadcyla.

    By End-User: Biopharmaceutical companies dominate due to their extensive investments in R&D and clinical trials, particularly in solid tumor oncology.

    These segments are expected to maintain their dominance through 2029 due to sustained innovation and commercial success.

    Competitive Landscape – Top 5 Companies
    The global ADC market is shaped by a few key players with robust pipelines, partnerships, and product portfolios:

    Seagen Inc. (now Pfizer)
    Seagen’s Adcetris and Padcev continue to perform well commercially. Post-acquisition by Pfizer, the company is scaling ADC production and accelerating global clinical trials in lung and urothelial cancers.

    AstraZeneca
    In collaboration with Daiichi Sankyo, AstraZeneca launched Enhertu and Datopotamab deruxtecan (Dato-DXd), both of which have shown superior outcomes in breast and lung cancer. They are investing in linker technology to reduce off-target effects.

    Roche Holding AG
    A pioneer with Kadcyla, Roche is expanding into next-gen ADCs using novel payloads. It’s working on combining ADCs with checkpoint inhibitors to drive synergistic effects in immunotherapy.

    Gilead Sciences (via Immunomedics acquisition)
    Gilead’s Trodelvy is gaining traction in triple-negative breast cancer. The company is expanding trials in bladder, ovarian, and lung cancers and enhancing internal ADC R&D capability.

    AbbVie
    AbbVie acquired ImmunoGen in 2023 to secure Elahere, an approved ADC for ovarian cancer. The company is also investing in ADC-manufacturing facilities and exploring novel cytotoxic payloads beyond tubulin inhibitors.

    These companies are redefining therapeutic delivery through innovation in linkers, payloads, and antibody engineering, creating a robust future pipeline.

    Regional Analysis: USA, UK, Germany, France, Japan, China
    United States: With the highest global share, the U.S. is supported by a pro-innovation regulatory environment, ample funding, and strong industry-academic partnerships.

    United Kingdom: The UK government has made significant investments in personalized oncology. Regulatory flexibility via the MHRA supports accelerated access to ADCs.

    Germany: Strong biotech infrastructure, including CDMO and GMP-compliant ADC manufacturing, is supporting robust clinical trial activity.

    France: Home to rising biotech firms like Innate Pharma, France is benefiting from EU-backed oncology projects and early-phase ADC development.

    Japan: Companies like Daiichi Sankyo are global leaders in ADC innovation. Regulatory fast-tracks for oncology drugs and international licensing deals contribute to Japan’s growing market share.

    China: A rapidly developing player, China is promoting domestic ADC development through subsidies and fast-track approvals. Several homegrown companies, such as RemeGen and Bio-Thera, are in late-stage trials.

    Conclusion and Analyst View
    The ADC technology market is one of the most dynamic areas in biopharmaceutical innovation. As the burden of cancer rises globally, ADCs offer a targeted and effective treatment pathway, revolutionizing the standard of care. With over 150 ADCs in the clinical pipeline and continuous investments from global pharma leaders, the market is primed for exponential growth.


    Related Report:

    Biometric payment market:https://www.maximizemarketresearch.com/market-report/biometric-payment-market/190525/

    Next generation computing market:https://www.maximizemarketresearch.com/market-report/next-generation-computing-market/190444/

    About Us

    Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

    MAXIMIZE MARKET RESEARCH PVT. LTD.
    2nd Floor, Navale IT park Phase 3,
    Pune Banglore Highway, Narhe
    Pune, Maharashtra 411041, India.

    +91 9607365656

    [email protected]
    Global Stirling Engine Market Size To Grow At A CAGR Of 9.6% In The Forecast Period Of 2023-2030 Antibody–Drug Conjugate (ADC) Technology Market is projected to expand from USD 6.5 billion in 2023 to USD 19.8 billion by 2029, growing at a CAGR of approximately 20.2% during the forecast period. This surge is fueled by the rising demand for targeted cancer therapies, expansion in oncology research, and breakthrough drug approvals, which are transforming the treatment landscape for solid tumors and hematologic malignancies. Request Free Sample Report:https://www.maximizemarketresearch.com/request-sample/216553/ Market Estimation, Growth Drivers & Opportunities ADCs represent a sophisticated drug delivery platform that merges the precision of monoclonal antibodies with the potency of cytotoxic drugs. This targeted approach is enabling higher efficacy and lower toxicity in treating cancers, particularly breast, bladder, and hematologic malignancies. Key Growth Drivers: Increasing cancer burden globally, with a growing demand for effective and less harmful therapies. High success rate of late-stage ADCs, particularly in HER2-positive and triple-negative breast cancer, driving physician and patient adoption. Collaborative R&D and licensing deals between biotech startups and pharmaceutical giants, speeding up clinical development and commercialization. Opportunities: Expansion into non-oncology indications, such as autoimmune diseases. Development of next-generation ADC linkers and site-specific conjugation technologies, enhancing stability and efficacy. Rising demand in Asia-Pacific for innovative oncology treatments due to increasing access to biologics.U.S. Market Trends and 2024 Investments The U.S. ADC market leads globally, accounting for over 40% of global revenue in 2024. Several trends and investments highlight the country's strategic focus: Pfizer’s acquisition of Seagen in 2023, worth $43 billion, marked a pivotal moment for the ADC space. This move bolstered Pfizer’s oncology pipeline with four marketed ADCs and several candidates in Phase II/III trials. FDA approvals of ADCs surged in 2023–2024, with significant attention to Enhertu (AstraZeneca/Daiichi Sankyo) and Elahere (ImmunoGen). NIH and BARDA funding initiatives are also supporting translational research on ADC payload optimization and companion diagnostics. This environment positions the U.S. as the primary innovation and commercialization hub for ADCs. Market Segmentation – Leading Segments by Share According to the segmentation analysis: By Type: The monoclonal antibodies (mAbs) segment held the largest share due to the widespread use of FDA-approved antibodies like trastuzumab and rituximab as carriers for ADCs. By Application: Breast cancer accounted for the largest share, driven by the success of HER2-targeted ADCs such as Enhertu and Kadcyla. By End-User: Biopharmaceutical companies dominate due to their extensive investments in R&D and clinical trials, particularly in solid tumor oncology. These segments are expected to maintain their dominance through 2029 due to sustained innovation and commercial success. Competitive Landscape – Top 5 Companies The global ADC market is shaped by a few key players with robust pipelines, partnerships, and product portfolios: Seagen Inc. (now Pfizer) Seagen’s Adcetris and Padcev continue to perform well commercially. Post-acquisition by Pfizer, the company is scaling ADC production and accelerating global clinical trials in lung and urothelial cancers. AstraZeneca In collaboration with Daiichi Sankyo, AstraZeneca launched Enhertu and Datopotamab deruxtecan (Dato-DXd), both of which have shown superior outcomes in breast and lung cancer. They are investing in linker technology to reduce off-target effects. Roche Holding AG A pioneer with Kadcyla, Roche is expanding into next-gen ADCs using novel payloads. It’s working on combining ADCs with checkpoint inhibitors to drive synergistic effects in immunotherapy. Gilead Sciences (via Immunomedics acquisition) Gilead’s Trodelvy is gaining traction in triple-negative breast cancer. The company is expanding trials in bladder, ovarian, and lung cancers and enhancing internal ADC R&D capability. AbbVie AbbVie acquired ImmunoGen in 2023 to secure Elahere, an approved ADC for ovarian cancer. The company is also investing in ADC-manufacturing facilities and exploring novel cytotoxic payloads beyond tubulin inhibitors. These companies are redefining therapeutic delivery through innovation in linkers, payloads, and antibody engineering, creating a robust future pipeline. Regional Analysis: USA, UK, Germany, France, Japan, China United States: With the highest global share, the U.S. is supported by a pro-innovation regulatory environment, ample funding, and strong industry-academic partnerships. United Kingdom: The UK government has made significant investments in personalized oncology. Regulatory flexibility via the MHRA supports accelerated access to ADCs. Germany: Strong biotech infrastructure, including CDMO and GMP-compliant ADC manufacturing, is supporting robust clinical trial activity. France: Home to rising biotech firms like Innate Pharma, France is benefiting from EU-backed oncology projects and early-phase ADC development. Japan: Companies like Daiichi Sankyo are global leaders in ADC innovation. Regulatory fast-tracks for oncology drugs and international licensing deals contribute to Japan’s growing market share. China: A rapidly developing player, China is promoting domestic ADC development through subsidies and fast-track approvals. Several homegrown companies, such as RemeGen and Bio-Thera, are in late-stage trials. Conclusion and Analyst View The ADC technology market is one of the most dynamic areas in biopharmaceutical innovation. As the burden of cancer rises globally, ADCs offer a targeted and effective treatment pathway, revolutionizing the standard of care. With over 150 ADCs in the clinical pipeline and continuous investments from global pharma leaders, the market is primed for exponential growth. Related Report: Biometric payment market:https://www.maximizemarketresearch.com/market-report/biometric-payment-market/190525/ Next generation computing market:https://www.maximizemarketresearch.com/market-report/next-generation-computing-market/190444/ About Us Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others. MAXIMIZE MARKET RESEARCH PVT. LTD. 2nd Floor, Navale IT park Phase 3, Pune Banglore Highway, Narhe Pune, Maharashtra 411041, India. +91 9607365656 [email protected]
    0 Comentários 0 Compartilhamentos 3526 Visualizações
Páginas impulsionada